Quick search:
Content Ideas
Result Content Idea Research
Result Content Idea Research
1 Pfizer ups COVID-19 vaccine revenue estimates from
2 Clean Biologics gains foothold in North American market, adds vaccine and biologics focused CDMO to group
3 Takara Bio Europe in stem cell licensing agreement
4 Biopharma Reporter Archives
5 Medicago's plant-based COVID-19 vaccine starts Health Canada rolling review
6 COVID-19: Meissner secures $13.4m BARDA award to produce single-use systems
7 Merck KGaA raises full-year forecast; Perlmutter's new gig tackles 'undruggable targets'
8 Ori Biotech and ATMPS merge tech to facilitate CGT production
9 Transforming how vaccines are made
10 PureTech talks breakthroughs in Alzheimer's disease treatment
11 UK launches human challenge trial on COVID-19 reinfection
12 SparingVision acquires GAMUT Therapeutics; expanding novel ocular disease pipeline
13 AI test could help with identifying cancer treatment approaches
14 AACR: Single-cell analysis transforming cancer research
15 Samsung Biologics and TG Therapeutics in CMO deal
16 The future of clinical trials: Are DCTs fast becoming the new norm?
17 Akston Biosciences takes second-generation COVID-19 vaccine into Phase 1/2 clinical trial
18 Kite: New data offers transparency into CAR T cell therapy manufacturing in real world setting
19 Malaria vaccine candidate first to reach WHO goal with 77% efficacy
20 Sanofi to help manufacture Moderna's COVID-19 vaccine in the US
21 Roche sees continued strong impact of biosimilars
22 All news articles for May 2021
23 Data shows antibody persistence for Moderna COVID-19 vaccine
24 Explore vital drug delivery innovations at online event
25 What are the next generation of drug delivery technologies to turn promising molecules into medicines of the future?
26 BeiGene gains commercial manufacturing approval for Guangzhou biologics facility
27 From biosimilars to process intensification: 5 key trends in the biopharma space today
28 UK opens up COVID-19 vaccination to pregnant women
29 TCR² Therapeutics establishes Maryland site for commercial-scale cell therapy manufacturing
30 Changing the paradigm: Microbiome modulation may become the next 'pillar' in cancer treatment
31 Abzena choses North Carolina for new $200m biologics manufacturing site
32 Bristol Myers Squibb to build new cell therapy manufacturing site in the Netherlands
33 Gene therapy trials: safety challenges
34 EU drafts order for 1.8 billion Pfizer/BioNTech COVID-19 vaccine doses
35 Regeneron's COVID-19 antibody cocktail protects against infection, says Phase 3 study
36 Moderna to take mRNA flu and HIV vaccines into Phase 1 trials this year
37 'Our center will tackle major challenges in gene therapy development': University of Sheffield to house new innovation and manufacturing hub
38 Israel sets up 2022 COVID-19 vaccine supply with Pfizer and Moderna
39 Cell and gene therapy services market forecast to see significant growth over the next decade
40 ADC Bio acquired, focus on Pfizer, Gilead, AZ, Daiichi deals
41 EU watchdog evaluates possible link between Johnson & Johnson jab and blood clots
42 Valneva takes COVID-19 vaccine candidate into Phase 3 trials
43 Positive study results said to support deployment of assay system in cancer drug clinical trials
44 AACR: AstraZeneca unveils early data for next-generation PARP inhibitor
45 Tetra Bio-Pharma (OTC: TBPMF) Signs Definitive Distribution Agreement with DanCann Pharma to Monetize Its Dronabinol and Botanical Product Portfolios
46 BioNTech starts production at Marburg COVID-19 vaccine site
47 Theravance Biopharma (TBPH) Reports Q1 Loss, Misses Revenue Estimates
48 Tetra Bio-Pharma (OTC: TBPMF) Re-activates Veterinary Clinical Study in Companion Animals
49 In the pipeline: What the next wave of COVID-19 vaccines could look like
50 Tetra Bio-Pharma (OTC: TBPMF) Granted a Drug Establishment License to Distribute REDUVO Soft Gel Capsules in Canada
51 Compulsory licensing is not an effective policy tool, warns EU biopharma group as it reacts to European IP action plan
52 A big week for mRNA COVID-19 vaccines: Pfizer, Moderna leap forward
53 Vaxart's oral COVID-19 tablet vaccine to enter clinical trials
54 Baxter BioPharma Solutions to perform fill/finish services for Moderna's COVID-19 vaccine
55 Moderna begins testing of its COVID-19 vaccine in children
56 AstraZeneca/Oxford to trial COVID-19 vaccine in children
57 Clinical trial set to test efficacy of mixing Sputnik V and COVID-19 Vaccine AstraZeneca
58 No strings attached: COVID-19 pandemic raises profile of non-dilutive funding for life science companies
59 How CureVac is creating a 'broad pipeline' of both first and second generation COVID-19 vaccines
60 Pfizer's COVID-19 vaccine is 'more than 90% effective'; according to Phase 3 interim analysis
61 eGenesis raises US$125m in Series C financing to 'transform' transplant medicine
62 Oxford University weighing up how vaccine platform would need to adapt to deal with variants
63 J&J launches Phase 3 trial for 2-dose COVID-19 vaccine
64 100-day vaccine development and an 'all-in-one' coronaviruses vaccine: CEPI's $3.5bn ambition
65 About us
66 The need for speed: Faster vaccine rollout critical to stronger recovery, says OECD
67 Australia announces deal for 84 million COVID-19 vaccine doses
68 Fujifilm Diosynth contracted by BARDA
69 EU gives BioNTech, AstraZeneca and Moderna green light for new COVID-19 production facilities
70 US listing set to support and accelerate ongoing development of 4D Pharma's live biotherapeutics
71 EU industry group warns new export rules threaten COVID-19 vaccine production and supply
72 Oxford-AstraZeneca COVID-19 vaccine granted emergency use authorization in multiple countries
73 Valneva and Pfizer start new Phase 2 study for Lyme disease vaccine candidate
74 Raft of Indian pharma firms set to produce Sputnik V vaccine
75 CureVac on track to apply for COVID-19 vaccine market authorization in Q2 2021
76 Johnson & Johnson starts Phase 3 trial for COVID-19 vaccine
77 France ramps up COVID-19 vaccine manufacturing
78 Valneva to create 'major UK vaccine facility' as part of UK COVID-19 deal
79 Johnson & Johnson to supply African Union with up to 400 million COVID-19 vaccine doses
80 Pfizer backing biotechnology innovation with $120m capital outlay
81 First patient dosed with AgenTus' cell therapy designed to clear COVID-19 virus while reducing inflammation
82 Baxter BioPharma Solutions to provide manufacturing services for Novavax's COVID-19 vaccine candidate
83 GSK expands its clinical trial manufacturing capacity at dedicated CGT facility in UK
84 Fujifilm expands its gene therapy drug CDMO business
85 Pfizer sells biosimilars plant in China to Wuxi
86 Affibody and Inmagene autoimmune partnership completes regulatory milestone
87 Is there a threat looming from new COVID-19 variant identified in the UK?
88 EU pledges to ramp up COVID-19 vaccine production; sets vaccination targets
89 J&J late-stage vaccine trials in September
90 Samsung Biologics' growth plans: manufacturing expansion and novel drug development
91 Rani gets financial backing to the tune of US$69m as it looks to bring injectable biologics the oral route
92 Pfizer/BioNTech COVID-19 vaccine is safe for elderly people, says WHO
93 EDQM releases text on COVID-19 recombinant viral vector vaccines
94 Early studies suggest Pfizer/BioNTech vaccine is effective against South African strain
95 AstraZeneca vaccine is safe and effective: EMA says jab not linked to increase in blood clot risk
96 Pfizer/BioNTech to trial COVID-19 vaccine in pregnant women and children
97 How vaccine manufacturers can prepare for the next pandemic
98 Johnson & Johnson starts rolling review for COVID-19 vaccine in Europe
99 Emergent 'on track' with COVID-19 vaccine production obligations, J&J takes control of Baltimore plant
100 Belgian trial to evaluate potential of genomic profiling of a patient's cancer to guide personalized treatment options